1. Home
  2. LEGN vs CALM Comparison

LEGN vs CALM Comparison

Compare LEGN & CALM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • CALM
  • Stock Information
  • Founded
  • LEGN 2014
  • CALM 1957
  • Country
  • LEGN United States
  • CALM United States
  • Employees
  • LEGN N/A
  • CALM N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • CALM Farming/Seeds/Milling
  • Sector
  • LEGN Health Care
  • CALM Consumer Staples
  • Exchange
  • LEGN Nasdaq
  • CALM Nasdaq
  • Market Cap
  • LEGN 5.4B
  • CALM 4.5B
  • IPO Year
  • LEGN 2020
  • CALM 1996
  • Fundamental
  • Price
  • LEGN $28.95
  • CALM $95.93
  • Analyst Decision
  • LEGN Strong Buy
  • CALM Sell
  • Analyst Count
  • LEGN 12
  • CALM 3
  • Target Price
  • LEGN $77.09
  • CALM $83.00
  • AVG Volume (30 Days)
  • LEGN 1.9M
  • CALM 799.2K
  • Earning Date
  • LEGN 05-13-2025
  • CALM 07-22-2025
  • Dividend Yield
  • LEGN N/A
  • CALM 7.02%
  • EPS Growth
  • LEGN N/A
  • CALM 258.93
  • EPS
  • LEGN N/A
  • CALM 20.24
  • Revenue
  • LEGN $728,303,000.00
  • CALM $3,799,016,000.00
  • Revenue This Year
  • LEGN $64.21
  • CALM $76.88
  • Revenue Next Year
  • LEGN $53.69
  • CALM N/A
  • P/E Ratio
  • LEGN N/A
  • CALM $4.74
  • Revenue Growth
  • LEGN 112.46
  • CALM 60.00
  • 52 Week Low
  • LEGN $27.34
  • CALM $57.43
  • 52 Week High
  • LEGN $60.87
  • CALM $116.41
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 41.56
  • CALM 53.18
  • Support Level
  • LEGN $28.13
  • CALM $92.42
  • Resistance Level
  • LEGN $29.31
  • CALM $96.67
  • Average True Range (ATR)
  • LEGN 1.63
  • CALM 2.24
  • MACD
  • LEGN 0.03
  • CALM -0.15
  • Stochastic Oscillator
  • LEGN 27.01
  • CALM 47.73

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About CALM Cal-Maine Foods Inc.

Cal-Maine Foods Inc produces and sells shell eggs. Its main market is the United States. The company's product portfolio contains nutritionally enhanced, cage-free, organic, and brown eggs. Cal-Maine Foods markets the shell eggs to a diverse group of customers, including grocery-store chains, club stores, and food service distributors. The company's brands are Egg-Land's, Land O' Lakes, Farmhouse, and 4-Grain. The Company has one reportable operating segment, which is the production, grading, packaging, marketing and distribution of shell eggs.

Share on Social Networks: